1. Home
  2. CTXR vs MYND Comparison

CTXR vs MYND Comparison

Compare CTXR & MYND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Citius Pharmaceuticals Inc.

CTXR

Citius Pharmaceuticals Inc.

HOLD

Current Price

$0.71

Market Cap

20.1M

Sector

Health Care

ML Signal

HOLD

Logo Mynd.ai Inc.

MYND

Mynd.ai Inc.

HOLD

Current Price

$0.42

Market Cap

21.2M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTXR
MYND
Founded
2007
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
20.1M
21.2M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
CTXR
MYND
Price
$0.71
$0.42
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
491.0K
13.8K
Earning Date
02-13-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,944,111.00
$209,800,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$147.57
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.63
$0.41
52 Week High
$2.97
$1.30

Technical Indicators

Market Signals
Indicator
CTXR
MYND
Relative Strength Index (RSI) 39.15 40.96
Support Level $0.70 $0.41
Resistance Level $0.95 $0.48
Average True Range (ATR) 0.08 0.06
MACD 0.01 -0.00
Stochastic Oscillator 10.92 7.14

Price Performance

Historical Comparison
CTXR
MYND

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products. It aims to provide therapeutic products that address unmet medical needs yet have a lower development risk than is usually associated with new chemical entities. The company's flagship product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein. It operates through a single operating and reportable segment which is focused on developing and commercializing pioneering targeted oncology therapies.

About MYND Mynd.ai Inc.

Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more. Geographically, it operates in United States and Rest of the world.

Share on Social Networks: